VC Funding Dips In Q3, But 2024 Already Bests Full-Year 2023
Mega-Round Surge Boosts Overall Totals
Data from Evaluate show that biopharma venture capital investment fell from $7.95bn in Q2 to $6.59bn in Q3, but both outpaced every quarter in 2023 as the financial market recovery continues.
